The Columbian: Thank you, E. coli: Vancouver’s Absci uses bacteria to make ‘exciting’ drug discoveries
Oct 31, 2021
The Columbian recently spoke to Absci founder and CEO Sean McClain about the company’s IPO, new office space, and the use of AI and machine learning to aid bioengineering and drug design projects.
Read the full article here:
www.absci.com/columbian-thank-you-e-coli